Kolexia
Perrier-Cornet Andréas
Pharmacien
Hôpital Bichat-Claude-Bernard
Paris, France
33 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Maladies de von Willebrand Syndromes myéloprolifératifs Maladie de von Willebrand de type 2 Thrombose Hémophilie B {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Industries

Takeda Pharmaceutical
10 collaboration(s)
Dernière en 2023
A+A
2 collaboration(s)
Dernière en 2021
CSL Behring
1 collaboration(s)
Dernière en 2020
Sysmex
1 collaboration(s)
Dernière en 2023

Dernières activités

04. Hémostase : coagulation et anticoagulants
Hématologie Congress 2022   30 mars 2022
Whole Blood Impedance Aggregometry: A Usefool Tool but Still Not the Gold Standard
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Traitements de la maladie des cauchemars
Médecine du Sommeil   01 septembre 2021
Successful Non-surgical Management and Use of Thrombopoietin Receptor Agonist in a Case of Spleen Injury in a Young Girl with von Willebrand Disease Type 2B
Abstracts of the XXVII Congress of the International Society on Thrombosis and Haemostasis, July 6–10, 2019   21 juin 2019
Dosage of Factor IX in Persons with Hemophilia B Treated with Recombinant FIX Linked to an IgG Fc Domain: Comparison of 3 Methods in a French Hospital
Abstracts of the XXVII Congress of the International Society on Thrombosis and Haemostasis, July 6–10, 2019   21 juin 2019
FVIII dosages in persons with haemophilia A treated with extended half-life products: From local biology to optimized patient management.
Haemophilia : the official journal of the World Federation of Hemophilia   17 juin 2019
PB236: Extended Half-life Factor VIII: From Biology to Patients’ Management Optimization
Abstracts of the 64th Annual Meeting of the Scientific Standardization Committee of the International Society on Thrombosis and Haemostasis, July 18–21, 2018   05 juillet 2018
Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms.
Platelets   01 novembre 2017
Développement d’un outil francophone de détection des prescriptions inappropriées chez l’adulte hospitalisé en médecine interne
Le Pharmacien Hospitalier et Clinicien   01 septembre 2015
Comparison of four drug interaction screening programs.
Revue medicale suisse   09 janvier 2013